Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
Regulatory-like FOXP3+Helios+CD4+ T conventional cells correlate with T-cell activation after Orca-T immunotherapy.
PMID 41758930 · PMC13197979 · Blood · 2026 · 8 claims · 6 setups
Orca-T immunotherapy leads to increased phenotypic T-cell activation compared with unmanipulated PBSC grafts, persisting for months after treatment.
-
Full-text index only
The landscape of responses to neoadjuvant immunotherapy in resectable Kirsten rat sarcoma viral oncogene homolog-mutant lung adenocarcinoma: Clinical heterogeneity and correlative immunologic analysis.
PMID 42011021 · PMC13096693 · Clinical and translational medicine · 2026 · 6 claims · 8 setups
KRAS-mutant LUAD patients show significantly poorer pathological response and inferior long-term survival after neoadjuvant immunotherapy compared to KRAS-wildtype patients
-
Full-text index only
Fibroblast-associated CTHRC1 as a key indicator of recurrence risk in prostate cancer.
PMID 41832493 · PMC13101373 · World journal of surgical oncology · 2026 · 7 claims · 8 setups
Pathological T stage, N stage, Gleason score, and TP53 mutation are associated with higher PRAD recurrence risk